Loading...
•
Dec 31, 2021
Azenta Q1 2022 Earnings Report
Reported continued double-digit growth and a strong balance sheet.
Key Takeaways
Azenta reported a strong start to fiscal year 2022, with revenue from continuing operations reaching $140 million, an 18% increase year-over-year, driven by robust demand for product and service offerings.
Revenue from continuing operations was $140 million, up 18% year over year.
Life Sciences Products revenue grew 10% year over year, driven by strength in automated ultra-cold storage systems.
Life Sciences Services revenue was up 24% year over year, with growth in both Sample Repository Solutions and Genomic Services.
Diluted EPS from continuing operations was $0.04 per share.
Azenta
Azenta
Forward Guidance
The Company announced revenue and earnings guidance for continuing operations for the second quarter of fiscal 2022. Revenue is expected to be in the range of $137 million to $147 million and non-GAAP diluted earnings per share for the second fiscal quarter is expected to be in the range of $0.07 to $0.15. GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.04) to $0.04.
Positive Outlook
- Revenue is expected to be in the range of $137 million to $147 million
- Non-GAAP diluted earnings per share for the second fiscal quarter is expected to be in the range of $0.07 to $0.15.
Challenges Ahead
- GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.04) to $0.04.